About SIMLANDI

SIMLANDI is a prescription medication containing the active ingredient Adalimumab, a fully human monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha). It is used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.

Key Benefits & Uses

Treatment of moderate to severe rheumatoid arthritis in adults, reducing symptoms and slowing disease progression.
Treatment of active psoriatic arthritis in adults, reducing symptoms and slowing disease progression.
Treatment of ankylosing spondylitis in adults, reducing symptoms and slowing disease progression.
Treatment of moderate to severe plaque psoriasis in adults, reducing symptoms and slowing disease progression.

Active Ingredient & Action

Adalimumab works by binding to TNF-alpha, a substance in the body that causes inflammation and is involved in autoimmune diseases. By blocking TNF-alpha, Adalimumab reduces inflammation and slows disease progression in the affected joints and skin.

Important Notes

SIMLANDI is available by prescription only and should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of side effects. Common side effects may include injection site reactions, headache, and fatigue. If you experience any unusual symptoms or side effects, consult your doctor or pharmacist immediately.